The following is a summary of “Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review,” published in the March 2025 issue of Advances in Rheumatology by Carvalho et al.
The post Outcomes of Rituximab and IVIg in Autoimmune Disorders first appeared on Physician’s Weekly.
